Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Stephen M. DeMoss who wrote (3554)	12/18/1999 10:07:00 PM
From: LiPolymer	Read Replies (2) \| Respond to of 4140

Even at $17.50 you still might want to read the fine print on this GCC tender offer. "Growth Capital Corporation expressly reserves the right, in its sole discretion, to purchase as many shares (up to 2,300,00) or as few shares as it deems advisable. Additionally, the company expressly reserves the right, in its sole discretion, to select which tendered shares it accepts or rejects regardless of the date tendered, and to extend the expiration of the offer under the same terms and conditions." So they lock up the tendered shares as long as they want, and don't ever have to actually buy any of them. After tendering shares, if SNRS tanks, you lose, and, if SNRS rockets, you still lose. Such a deal! I really hope nobody tenders any shares to these bandits. Regards, Gary